WSFG
REGN icon

Wall Street Financial Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Wall Street Financial Group’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-125
Closed -$96.6K – 505
2026
Q1 		$96.6K Buy
+125
New +$95.7K 0.06% 195

Other funds holding REGN

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
MCI
McDonald Capital Investors Orinda, California $1.37B AUM 1.88% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Retirement Systems of Alabama
Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Wall Street Financial Group's REGN Position: Q2 2026 in Review

Wall Street Financial Group sold out of Regeneron Pharmaceuticals (REGN) in Q2 2026, closing a stake of 125 shares — an estimated $96.6K sold.

Wall Street Financial Group first reported a position in REGN in Q1 2026 and held it in 1 quarter. The position peaked at $96.6K in Q1 2026. 459 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Wall Street Financial Group reported no remaining Regeneron Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Wall Street Financial Group sold 125 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $96.6K.
  • Wall Street Financial Group first reported a position in Regeneron Pharmaceuticals in Q1 2026 and held it in 1 quarter.
  • Wall Street Financial Group's Regeneron Pharmaceuticals position peaked at $96.6K in Q1 2026.
  • 459 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Wall Street Financial Group's 13F filing for Q2 2026, filed 14 Jul 2026.